Skip to content
★ Sign in to follow
Hangzhou Zhongtai Cryogenic Technology Corporation logo

Hangzhou Zhongtai Cryogenic Technology Corporation Stock: price and insider trades · China

中泰股份

CN·Mcap CN¥5.6BIndustrials

No insider purchase over the last 90 days. The latest, by 方俊杰, was filed 05 Jan 2024.

Hangzhou Zhongtai Cryogenic Technology Corporation: what insiders have been doing

Every trade that managers of Hangzhou Zhongtai Cryogenic Technology Corporation disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Industrials sector. 2 insiders have disclosed 3 filings since 5 November 2025.

Only sales appear on the open market, 3 sales in all totalling €2.0M, filed by 2 insiders. 章有虎 filed the largest sale, €1.4M, on 14 January 2026.

With 3 filings in twelve months, the company is more active than the median of 2 filings across the 521 companies we follow on the same exchange. Since 2021, the database holds 1 purchase and 7 sales by insiders of the company.

Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. That lag is the time during which only the insider knows about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.

Elsewhere in the same sector, our signals recently picked up insider purchases at Auroora Yhtiöt Oyj and MBB SE. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
8
Thresholds
n/a
Buy Volume
€723
1 ops. · all time
Sell Volume
€6M
7 ops. · all time

Who traded when

BuySale
章有虎2 sales
俞富灿1 sale

Since the insiders bought

  • Filed 05 Jan 2024 · 1038 days ago · €723
    -16.8%
    Entry CN¥13.61 · Close at T+365 CN¥11.33

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 3,089 of 26,914 companies
72.9
score / 100
Value
73
Quality
73
FCF yld7.9%
Earn yld8.0%
EV/EBITDA8.4x
ROE13%
Gross mgn30%
Net mgn16%
Debt/EBITDA0.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥14.60
Analyst consensus
·
Income statement
RevenueCN¥2.8B
Gross profitCN¥816.9M30% margin
EBITDACN¥679.6M25% margin
Net incomeCN¥450.4M16.9% margin
Valuation
PER (trailing)12.6x
P/Book1.6x
Beta0.66
Balance sheet & cash
Market capCN¥5.6B
Total debtCN¥101M
Free Cash FlowCN¥445.4M
Debt / Equity6%
Profitability & ownership
ROE13.4%
ROA7.2%
% insiders39.6%
% institutions2.4%
Last declaration on 22 January 2026
Declarations8 total
  • ▼
    董事,高管Executives
    4M CNY20SZSE
    100,000 shares8.3% of flowA股XSHESZSE:273000000142598660
  • ▼
    董事,高管Executives
    12M CNY22SZSE
    400,000 shares27.5% of flowA股XSHESZSE:273000000114678430
  • ▼
    董事Executives
    1M CNY12SZSE
    36,600 shares47.2% of flowA股XSHESZSE:273000000108446270
  • ▲
    监事Executives
    5,644 CNY15SZSE
    400 shares100.0% of flowA股XSHESZSE:173000007223082500
    Canonical exit: 4 Apr 2024 (T+90)
  • ▼
    董事,高管Executives
    14M CNY23SZSE
    488,000 shares37.8% of flowA股XSHESZSE:173000005162015070
  • ▼
    董事,高管Executives
    550,000 CNY15SZSE
    20,000 shares100.0% of flowA股XSHESZSE:173000005098312130
  • ▼
    董事,高管Executives
    11M CNY22SZSE
    418,000 shares26.4% of flowA股XSHESZSE:173000004799263780
  • ▼
    董事Executives
    1M CNY24SZSE
    48,887 shares52.8% of flowA股XSHESZSE:173000004799266430

8 of 8 declarations

About Hangzhou Zhongtai Cryogenic Technology Corporation

中泰股份 is a Chinese company operating in the industrial sector, listed on the Shenzhen Stock Exchange. It specializes in the manufacturing and sale of various industrial products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations